Vaccine Therapy in Treating Patients With Metastatic Cancer

Clinical trial NCT00021164 · COMPLETED

Trial details

NCT number: NCT00021164
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2001-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.